dalazatide

DRUG2 trials

Sponsors

Kineta Inc.

Conditions

HealthyPlaque Psoriasis

Phase 1

A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis

CompletedNCT02435342

Kineta Inc.Plaque Psoriasis

Start: 2014-10-31End: 2015-03-31Updated: 2015-05-06

Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers

CompletedNCT02446340

Kineta Inc.Healthy

Start: 2013-11-30End: 2014-04-30Updated: 2015-05-18